Women’s History Month is a useful reminder that history is not a shelf we visit once a year. It is a blueprint. If we want a future where technology improves health instead of scaling inequity, we have to understand who has been building the world we live in, and who has been left out of the rooms where “progress” gets designed.
We are entering a decade where healthcare decisions will increasingly be influenced by code.
Risk scores, automated triage, decision tools and data-driven systems will shape who gets flagged early, who gets referred, who gets believed, and who gets left waiting. That is why the conversation about Black innovation in medicine cannot be confined to February. The stakes are too current.
Black women have expanded what medicine can do. The question now is whether our systems, and our technology, will expand who medicine is for.
The genius, and the gap
Disparities are often discussed as data. But they are experienced as friction.
Friction is the specialist who is too far away. The appointment that takes months. The preventive visit that becomes optional because life is not designed to pause. The prescription that is technically available, but financially out of reach. The symptoms that are minimized until they become emergencies.
This is not simply about individual decision-making. Disparities are the predictable result of systems, where care is easier to access in some ZIP codes than others, where consistent coverage is not guaranteed, and where time, transportation and trust become unspoken prerequisites for survival.
That word, trust, matters more than many policymakers admit. Trust is not just a feeling. It is a condition for care.
Dr. Myiesha Taylor and the power of representation as health infrastructure
Not every medical innovation looks like a device. Some innovations change the conditions around health itself, what communities trust, what children imagine, and what care feels like.
In a media ecosystem where identity is shaped by screens long before it is shaped by clinics, representation becomes a form of infrastructure. It is one reason a children’s character like Doc McStuffins mattered to so many families. Disney named the mother character in the series after Dr. Myiesha Taylor, a real physician who advocates for greater visibility of women doctors of color. In an era when health myths and misinformation travel faster than public health guidance, that kind of cultural signal is not cosmetic. It changes who is seen as credible. It changes who is imagined as a healer. It changes whether a child grows up thinking the white coat can belong to them.
If we are serious about equity, we have to treat trust-building as part of the delivery system, not an optional add-on.
Dr. Kizzmekia Corbett-Helaire and the politics of who benefits from discovery
Dr. Kizzmekia Corbett-Helaire represents the modern edge of scientific invention, the kind that moves at pandemic speed and global scale.
Her work in viral immunology and vaccine development helped propel the design and rapid translation of mRNA-1273, the Moderna COVID-19 vaccine, from sequence to real-world deployment. In a public health crisis, that is what invention looks like: not only insight, but execution, and the ability to turn knowledge into protection.
But the pandemic also exposed a familiar truth. Innovation does not automatically equal equity.
A vaccine can be designed brilliantly and still reach communities unevenly. A scientific breakthrough can exist and still be filtered through distrust, access barriers, uneven distribution, and political choices that leave some communities more exposed than others. The problem is not that science moves too fast. The problem is that our delivery systems, and our information systems, do not move fairly.
Corbett-Helaire’s presence in the rooms where that science was developed is part of why this column is not simply about celebration. It is about design. If the people most affected by disparities are missing from discovery, the wrong problems get prioritized. If they are missing from delivery, the right solutions arrive too late. If they are missing from governance, inequity becomes the default setting.
Dr. Marilyn Hughes Gaston and the invention of primary care access
If Corbett-Helaire represents discovery at scale, Dr. Marilyn Hughes Gaston represents something just as vital: institution-building at scale.
Gaston is widely recognized for leadership that reshaped how the nation treats sickle cell disease, and for her public health work focused on poor and underserved families. She also broke barriers at the federal level, including becoming the first Black woman to direct a U.S. Public Health Service bureau, leading HRSA’s Bureau of Primary Health Care.
This is the part of “innovation” that is easiest to overlook, because it is not glamorous. It is structural.
Primary care is where lives are extended quietly. It is where chronic conditions get managed before they become irreversible. It is where prevention has a chance to work. When primary care is thin, disparities thicken. Emergency rooms become the entry point. Late diagnosis becomes routine. The system becomes reactive, and people with the least margin pay the highest price.
Gaston’s work makes a point that should guide every conversation about health equity today: a cure is not the same thing as care. Care requires a network, a workforce, funding, and continuity. It requires policy choices that treat access as a public responsibility.
The next frontier is AI, and the stakes are global
The moral test of this moment is not whether medicine will become more advanced. It will.
The test is whether the next generation of tools will narrow inequity, or encode it and scale it.
Healthcare is increasingly shaped by data-driven models, risk scores, automated triage, and algorithmic decision support. These tools can improve outcomes, but only if they are built with diverse expertise, tested on diverse populations, and governed with real accountability.
If the rooms where these tools are designed do not include the people most affected by disparities, inequity becomes a design feature. Not because anyone says so out loud, but because systems quietly optimize for the wrong proxies, and the people pushed to the margins pay the cost.
This is where Black women’s leadership becomes a global equity issue, not a domestic talking point. Diverse voices in science and tech, especially healthcare tech, are not symbolic. They are safety. They are quality control. They are the difference between a future that expands health, and a future that rationed it with better software.
What it means to honor Black women innovators
This series is not about nostalgia. It is about power.
Dr. Myiesha Taylor’s story shows that cultural visibility can shape trust, and trust can shape access. Dr. Kizzmekia Corbett-Helaire’s work shows that discovery can move with breathtaking speed, but equity still depends on delivery. Dr. Marilyn Hughes Gaston’s leadership shows that systems are not neutral, they are built, funded, and maintained, or allowed to thin until disparities become “normal.”
Black women have helped build modern medicine, in laboratories, in federal agencies, in communities, and even in the stories children absorb before they can name what they are learning.
The thought leadership question for our time is whether we will build systems worthy of that work.
Because the real threat is not that innovation will slow down. The real threat is that inequity will keep up.
Sources
Harvard T.H. Chan School of Public Health, profile of Dr. Kizzmekia S. Corbett-Helaire (mentions work supporting development of mRNA-1273 and rapid translation to Moderna): https://hsph.harvard.edu/profile/kizzmekia-s-corbett-helaire/
PubMed, “SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness” (Corbett listed as author, describes mRNA-1273 results in preclinical studies): https://pubmed.ncbi.nlm.nih.gov/32756549/
American College of Obstetricians and Gynecologists, “Marilyn Hughes Gaston, MD: A Public Health Innovator and Leader” (HRSA Bureau of Primary Health Care leadership and barrier-breaking): https://www.acog.org/news/news-articles/2026/02/marilyn-hughes-gaston-md-a-public-health-innovator-and-leader
University of Illinois Chicago, College of Medicine, “Marilyn Hughes Gaston, MD” (director of HRSA Bureau of Primary Health Care, focus on poor and underserved families): https://chicago.medicine.uic.edu/medicine/about-us/diversity-inclusion/black-history-profile/marilyn-hughes-gaston/
The Dallas Morning News, “Doc McStuffins to pay tribute to local doctor” (naming of the mother character in honor of Dr. Myiesha Taylor): https://www.dallasnews.com/arts-entertainment/architecture/2013/12/19/television-doc-mcstuffins-to-pay-tribute-to-local-doctor-in-january/
ACEP Now, “Emergency Physician Myiesha Taylor Helps Promote Diversity with Doc McStuffins TV Character” (discussion of naming and purpose): https://www.acepnow.com/article/emergency-physician-myiesha-taylor-helps-promote-diversity-doc-mcstuffins-tv-character/2/JET Magazine, “Disney’s ‘Doc McStuffins’ Honors Dr. Myiesha Taylor” (coverage of the naming and recognition): https://www.jetmag.com/life/disneys-doc-mcstuffins-honors-dr-myiesha-taylor/
